on Laxxon Medical
Laxxon Medical to Host Fireside Chat at UBS Healthcare Conference
Laxxon Medical Corp., a leader in pharma technology for oral drug delivery, has announced its participation in the upcoming UBS Global Healthcare Conference. The event is scheduled for November 14th, 2024, at Rancho Palos Verdes, California. Laxxon’s CEO Helmut Kerschbaumer will lead the discussion, along with key executives Alexander Ruckdaeschel and Lauren Chung. The session will be moderated by a representative from UBS.
The conference is known for bringing together top C-Suite executives and institutional investors. Sessions will include one-on-one meetings and panels, providing networking opportunities with industry experts. A recording of the Laxxon session will be accessible on their website, under the investors' page.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Laxxon Medical news